Variant report
Variant | esv1971875 |
---|---|
Chromosome Location | chr2:31808512-31808927 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SRD5A2 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189338643 | chr2:31808533-31808534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181995565 | chr2:31808602-31808603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540654876 | chr2:31808619-31808620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150999237 | chr2:31808648-31808649 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs548406938 | chr2:31808655-31808656 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75584848 | chr2:31808682-31808683 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564405810 | chr2:31808698-31808699 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373996351 | chr2:31808707-31808708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138287024 | chr2:31808708-31808709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10221708 | chr2:31808720-31808721 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76149788 | chr2:31808721-31808722 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114777141 | chr2:31808753-31808754 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536071224 | chr2:31808798-31808799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140884236 | chr2:31808799-31808800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556024190 | chr2:31808806-31808807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs675222 | chr2:31808820-31808821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs510829 | chr2:31808862-31808863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs565230966 | chr2:31808884-31808885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs371782977 | chr2:31808891-31808892 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs72867544 | chr2:31808895-31808896 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs533019124 | chr2:31808922-31808923 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Cancer | 16751803 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21509527 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:31806600-31811800 | Weak transcription | Liver | Liver |
2 | chr2:31808600-31809400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr2:31808800-31809000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |